Abdominal MRI (Visceral Fat / Organ Screening)
A full abdominal MRI, sold in some longevity packages as a way to image visceral fat directly and screen abdominal and pelvic organs for incidental disease. MRI-measured visceral fat volume is the research gold standard, more accurate than DEXA, and organ imaging can occasionally catch unexpected pathology. Both statements are true, and neither one makes this a screening test.
Large research cohorts such as the UK Biobank imaging sub-study use abdominal MRI to quantify visceral fat precisely — as a research protocol, not a validated clinical screening pathway for asymptomatic adults. Deployed as a general “screen everything” tool it produces a high rate of incidental findings, from benign cysts to indeterminate nodules, generating follow-up imaging, biopsies and anxiety without a proven net mortality or morbidity benefit. No professional guideline recommends whole-abdomen MRI screening in asymptomatic average-risk adults.